Here are five updates on GI companies from the past week.
GI & Endoscopy
Megan Adams, MD, is a gastroenterologist at Ann Arbor-based Michigan Medicine Gastroenterology Clinic.
Allergan entered into a clinical trial agreement with Novartis to conduct a phase 2b study of Allergan's cenicriviroc and Novartis' lead FXR agonist in treating non-alcoholic steatohepatitis.
Researchers from the University of Nebraska-Lincoln created an autonomous colonoscopy robot, the Daily Nebraskan reports.
There's a great medical need for new therapies aimed at treating irritable bowel syndrome, according to FDA gastroenterologist Tara Altepeter, MD.
According to data released by the CDC, Crohn's disease-related hospitalizations remained stable between 2003 and 2013 despite new therapies aimed at reducing remission and hospitalizations.
The Physician-Focused Payment Model Technical Advisory Committee recently completed its two-day public meeting to deliberate and vote on three proposals for physician-focused payment models.
Brent Gray, MD, is a gastroenterologist at College Station-based Central Texas Gastroenterology Consultants.
Tucson-based University of Arizona gastroenterologist Bhaskar Banerjee, MD, and colleagues are creating a dual-view endoscope to improve physician vision during colonoscopy, Arizona Public Media reports.
Medscape released "Gastroenterologist Physician Compensation Report 2017."
